147 related articles for article (PubMed ID: 15371450)
1. Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B.
Potthast R; Abbey-Hosch SE; Antos LK; Marchant JS; Kuhn M; Potter LR
J Biol Chem; 2004 Nov; 279(47):48513-9. PubMed ID: 15371450
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
Potter LR
Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue: a possible mechanism of heterologous desensitization.
Potter LR; Hunter T
J Biol Chem; 2000 Oct; 275(40):31099-106. PubMed ID: 10915802
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of NPR-B/GC-B by protein kinase c and calcium.
Abbey-Hosch SE; Smirnov D; Potter LR
Biochem Pharmacol; 2005 Sep; 70(5):686-94. PubMed ID: 16005434
[TBL] [Abstract][Full Text] [Related]
5. The atrial natriuretic peptide receptor (NPR-A/GC-A) is dephosphorylated by distinct microcystin-sensitive and magnesium-dependent protein phosphatases.
Bryan PM; Potter LR
J Biol Chem; 2002 May; 277(18):16041-7. PubMed ID: 11821394
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
Abbey SE; Potter LR
Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptors.
Potthast R; Potter LR
Peptides; 2005 Jun; 26(6):1001-8. PubMed ID: 15911068
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize.
Fan D; Bryan PM; Antos LK; Potthast RJ; Potter LR
Mol Pharmacol; 2005 Jan; 67(1):174-83. PubMed ID: 15459247
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B).
Abbey-Hosch SE; Cody AN; Potter LR
Hypertension; 2004 May; 43(5):1103-9. PubMed ID: 15037564
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta.
Drewett JG; Fendly BM; Garbers DL; Lowe DG
J Biol Chem; 1995 Mar; 270(9):4668-74. PubMed ID: 7876238
[TBL] [Abstract][Full Text] [Related]
11. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclic GMP and calcineurin in homologous and heterologous desensitization of natriuretic peptide receptor-A.
Fortin Y; De Léan A
Can J Physiol Pharmacol; 2006 May; 84(5):539-46. PubMed ID: 16902599
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations.
Abbey SE; Potter LR
J Biol Chem; 2002 Nov; 277(45):42423-30. PubMed ID: 12196532
[TBL] [Abstract][Full Text] [Related]
14. A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A.
Bryan PM; Smirnov D; Smolenski A; Feil S; Feil R; Hofmann F; Lohmann S; Potter LR
Biochemistry; 2006 Jan; 45(4):1295-303. PubMed ID: 16430226
[TBL] [Abstract][Full Text] [Related]
15. A constitutively "phosphorylated" guanylyl cyclase-linked atrial natriuretic peptide receptor mutant is resistant to desensitization.
Potter LR; Hunter T
Mol Biol Cell; 1999 Jun; 10(6):1811-20. PubMed ID: 10359598
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor.
Potter LR; Hunter T
J Biol Chem; 1998 Jun; 273(25):15533-9. PubMed ID: 9624142
[TBL] [Abstract][Full Text] [Related]
17. Regulation of natriuretic peptide receptors by thyrotropin in FRTL-5 rat thyroid cells: evidence for nonguanylate cyclase atrial natriuretic factor-binding sites in cells lacking the natriuretic peptide receptor C.
Sellitti DF; Doi SQ
Endocrinology; 1999 Mar; 140(3):1365-74. PubMed ID: 10067864
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the phosphorylation sites of the guanylyl cyclase-linked natriuretic peptide receptors A and B.
Potter LR; Hunter T
Methods; 1999 Dec; 19(4):506-20. PubMed ID: 10581150
[TBL] [Abstract][Full Text] [Related]
19. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
20. Presence of functional type B natriuretic peptide receptor in human ocular cells.
Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
